1. Get the Diabetes Forum App for your phone - available on iOS and Android.
    Dismiss Notice
  2. Guest, we'd love to know what you think about the forum! Take the Diabetes Forum Survey 2021 »
    Dismiss Notice
  3. Diabetes Forum should not be used in an emergency and does not replace your healthcare professional relationship. Posts can be seen by the public.
    Dismiss Notice
  4. Guest, stay home, stay safe, save the NHS. Stay up to date with information about keeping yourself and people around you safe here and GOV.UK: Coronavirus (COVID-19). Think you have symptoms? NHS 111 service is available here.
    Dismiss Notice
Dismiss Notice
Find support, ask questions and share your experiences. Join the community »

Medtronic and DreaMed partner to produce artificial pancreas

Discussion in 'Diabetes News' started by DCUK NewsBot, Apr 7, 2015.

  1. DCUK NewsBot

    DCUK NewsBot · Well-Known Member

    Likes Received:
    Trophy Points:
    Insulin pump manufacturer Medtronic has made another key move towards developing a commercially available artificial pancreas by partnering with an Israeli company, DreaMed Diabetes, which has been working on artificial pancreas algorithms for a number of years. Medtronic has made no secret that the development of a fully functional artificial pancreas is its primary objective and by teaming up with DreaMed, Medtronic should be able to realise this objective within a shorter timescale. The news is very exciting for people with type 1 diabetes. The development of an insulin pump-based artificial pancreas requires an insulin pump, continuous glucose monitoring sensors (CGM sensors) and advanced software to calculate the correct insulin delivery to give in response to changes in blood glucose levels. The partnership is a strong pairing. Medtronic is the market leader in insulin pumps and has already made strong in-roads into developing artificial pancreas technology. Medtronic's latest pump, the MiniMed 640G is the most sophisticated insulin pump that is currently commercially available. The pump, when used with CGM sensors has the ability to predict when hypoglycemia is likely to occur and switch off insulin delivery until the threat has passed. On the other side of the pairing is DreaMed, a company that has been developing artificial pancreas algorithms for a number of years and carried out a number of clinical trials, since 2007, to prove their success. DreaMed's Glucositter technology includes their MD-Logic algorithm, which makes use of 'fuzzy logic'. The technology also boasts the capability of being patient tailored, that is the software has the ability to learn individual characteristics of different people. Whilst the technology, in its current form, will require some decisions to be made by the patient, the advantage is that the technology will be able to help to correct errors, at both ends of the high and low blood sugar spectrum, in a way in which current insulin pumps with CGM functionality are not yet able to do.

    Continue reading...
  2. Donkeymad

    Donkeymad Type 1 · Active Member

    Likes Received:
    Trophy Points:
    This sounds very exciting, if only it were available - many years ago. Any time soon will be fantastic.
  • Meet the Community

    Find support, connect with others, ask questions and share your experiences with people with diabetes, their carers and family.

    Did you know: 7 out of 10 people improve their understanding of diabetes within 6 months of being a Diabetes Forum member. Get the Diabetes Forum App and stay connected on iOS and Android

    Grab the app!
  • Tweet with us

  • Like us on Facebook